Office Hours - Mon to Sat - 9:00 to 19:00 Hrs
Biotech companies face high costs and long development cycles. As a result, structured finance offers flexible funding to meet their specific needs. This ensures that they can maintain smooth operations and continue to innovate without experiencing disruptions to their cash flow. Furthermore, for larger funding needs, structured finance solutions can combine multiple financial instruments to create custom liquidity strategies, supporting R&D investments, acquisitions, and expansion plans.
Financing Tailored to Your Business
Finances assets like real estate, equipment, and working capital
Customizable Repayment
Used for large or complex projects.
Finances projects that traditional financing won’t
(*T&C Applied)
Structured finance not only provides biotech companies with customized funding solutions but also ensures steady growth.
Let’s Schedule a Call to Arrange Funding for your Biotechnology Company!
Biotechnology firms seeking structured finance must meet specific criteria to qualify.
Proper documentation speeds up the loan approval process. Here are the essential documents required for biotech structured finance:
At Terkar Capital, we understand the financial needs of biotechnology companies. Whether you’re developing new drugs, scaling up production, or investing in advanced research, we offer structured finance solutions that match your business requirements. Our expertise in biotech financing ensures that you get customized funding with flexible terms, making your growth journey smoother.
We work closely with biotech firms to assess their unique financial situation and provide structured funding solutions that minimize risks and maximize business potential. With our strong network of financial institutions and strategic funding models, we help biotech companies secure the right financial support.
Download our Company Profile to Get Brief Insights About Us!
Structured finance offers biotech companies flexible repayment, customized structures, and diverse funding sources, ideal for high R&D costs.
Yes, biotech startups can qualify if they have a strong business model, growth potential, and a clear financial plan outlining fund utilization.
Biotech firms involved in pharmaceuticals, bioengineering, diagnostics, and agricultural biotechnology can apply.
Not always. While collateral can enhance loan terms, structured finance can also be arranged based on projected revenue and business potential.
Currently, our focus is on biotechnology firms operating in India.
Check your CIBIL score for free.
Nashik | Nagpur | Chhatrapati Sambhaji Nagar | Hyderabad
Delhi | Bengaluru | Chennai | Kolkata | Ahmedabad | Surat
Growing Nationwide…